HDAC9 and amyotrophic lateral sclerosis: Since epigenetic drugs are at present one of the most promising strategies for ALS treatment, information on the physical, and functional interaction between TDP-43 and HDAC1 will provide the rationale for using the HDAC inhibitor (HDACi) in ALS therapy25.